Delivery Order SPE2DR25D3404-SPE2DR26F5U7D
- Not listed
- The Defense Logistics Agency awarded a $1,707.46 delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100 count). This firm fixed-price contract, which carries an ultimate completion date of December 11, 2025, represents a non-set-aside competitive award to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,310.10 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100 count) on December 8, 2025, with completion targeted for December 9, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $1,024.06 to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 20 mg capsules (100 count) on December 16, 2025, with completion due by December 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger federal pharmaceutical supply agreements. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Dextroamphetamine-Amphetamine 15 mg capsules (100 count) with a ceiling value of $1,131.09. This is a firm fixed price delivery order with no set-aside designation, issued competitively. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 15, 2025. This delivery order is...
- The Defense Logistics Agency awarded a $2,049.86 delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100 count). This firm fixed-price delivery order, with completion scheduled for December 11, 2025, represents a child contract issued under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The contract carries no set-aside designation, indicating it was competitively...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100 count) with a ceiling value of $5,248.30. This firm fixed-price delivery order, which is not set-aside restricted, represents a competitively awarded transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100 count) with a ceiling value of $2,155.26 and a completion date of November 13, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger federal contract vehicle. The performance location is the contractor's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,267.06 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100-count) on September 19, 2025, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price delivery order utilizes no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a child order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 20 mg capsules (100-count) with a ceiling value of $3,167.82. The award, issued on December 17, 2025, with an ultimate completion date of December 18, 2025, is a firm fixed-price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,207.24 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units). This non-competitive, firm fixed-price delivery order was issued on September 24, 2025, with an ultimate completion date of September 25, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued...
- SPE2DR25D3404Indefinite Delivery Contract
- SPE2DR25D3404-SPE2DR26F5U7DDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,629.43 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units). This competitive, firm fixed-price delivery order was executed on December 17, 2025, with an ultimate completion date of December 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. As a prime vendor for the DLA Medical Supply Chain, the company supplies a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for controlled-release amphetamine products supports the company's ongoing role as a critical supplier of neurological and behavioral health medications to Department of Defense and other federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 12/16/25 |